Doctors at a New York hospital have successfully cured sickle cell anemia in a 21-year-old man using lovotibeglogene autotemcel, an FDA -approved autologous hematopoietic stem cell-based gene therapy . He became the first person in New York to receive this treatment in December 2024. The patient had suffered from chronic pain for 21 years. According to his mother, he had been receiving treatment at this hospital since he was two months old.
A physician specializing in Pediatric Hematology and Oncology emphasized that over 100 years after sickle cell anemia was first identified, we are now witnessing its first true cure. Following his recovery, the patient looks forward to traveling, exercising, and pursuing his education. Feeling unstoppable, he plans to return to his daily life and work in the medical field. The hospital is also eager to expand access to this life-changing therapy…
